A once-weekly growth hormone replacement therapy demonstrated superiority over placebo for patients with adult growth hormone deficiency.
The FDA has granted 510(k) clearance to the Hyperfine system (Hyperfine Research), a bedside magnetic resonance imaging (MRI) system.
Researchers sought to better understand the clinical practice patterns of ob-gyn physicians regarding their screening practices and management of depression during menopause.
Researchers have developed an artificial intelligence (AI)-driven, noninvasive technology that is capable of detecting nocturnal hypoglycemic events from raw ECG signals without the need for a finger-prick test.
Changes in arterial stiffness are greater within one year of a woman’s final menstrual period.
A continuous behavioral lifestyle intervention supported by a smartphone app can assist in improving dietary intake and physical activity among pregnant women with overweight and obesity.
A group of medical professionals in southern states opposes proposals that would limit transgender minors’ access to gender-affirming health care such as hormone therapy and surgery.
Nutrition, pollution, stress, and harsh skin care — climate and sun exposure, too — may be the most frequent contributing factors to acne, according to a large, international study.
The Food and Drug Administration has approved a new formulation of Pancreaze (pancrelipase; Vivus) Delayed Release Capsules which would allow for an extended shelf life of 36 months.
In an effort to prevent and lower the risk of inflammation-related diseases, a multi-institutional team of researchers based in the United States, South America, and Europe are calling for improvements to the way in which systemic chronic inflammation is diagnosed and treated.
A study found that patients with anorexia nervosa have a particularly high risk for hip, vertebral, and upper arm fractures.